EPACADOSTAT for Malignant melanoma: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 8 adverse event reports in the FDA FAERS database where EPACADOSTAT was used for Malignant melanoma.
Most Reported Side Effects for EPACADOSTAT
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Dyspnoea | 12 | 12.4% | 3 | 11 |
| Diarrhoea | 9 | 9.3% | 2 | 9 |
| Febrile neutropenia | 9 | 9.3% | 0 | 9 |
| Pyrexia | 9 | 9.3% | 3 | 9 |
| Abdominal pain | 8 | 8.3% | 3 | 8 |
| Syncope | 8 | 8.3% | 1 | 8 |
| Anaemia | 7 | 7.2% | 2 | 7 |
| Sepsis | 7 | 7.2% | 2 | 7 |
| Vomiting | 7 | 7.2% | 2 | 7 |
| Fatigue | 6 | 6.2% | 1 | 5 |
| Acute kidney injury | 5 | 5.2% | 1 | 5 |
| Dehydration | 5 | 5.2% | 1 | 5 |
| Exfoliative rash | 5 | 5.2% | 0 | 5 |
| Nausea | 5 | 5.2% | 2 | 5 |
| Neutropenia | 5 | 5.2% | 1 | 5 |
Other Indications for EPACADOSTAT
Non-small cell lung cancer (19)
Neoplasm malignant (9)
Non-small cell lung cancer metastatic (7)
Product used for unknown indication (6)
Diffuse large b-cell lymphoma (5)
Other Drugs Used for Malignant melanoma
NIVOLUMAB (10,599)
IPILIMUMAB (8,903)
DABRAFENIB (5,277)
TRAMETINIB DIMETHYL SULFOXIDE (3,841)
PEMBROLIZUMAB (3,261)
BINIMETINIB (2,613)
ENCORAFENIB (2,591)
VEMURAFENIB (2,548)
TRAMETINIB (1,448)
COBIMETINIB (1,324)